Home > Healthcare > Medical Devices > Therapeutic Devices > Infertility Treatment Devices Market

Infertility Treatment Devices Market Trends

Report ID: GMI6134
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Infertility Treatment Devices Market Trends

Increase in the prevalence rate of infertility is attributed to various factors such as obesity and adoption of unhealthy dietary habits including excessive alcohol consumption & smoking, recreational drug consumption, among others. In addition, exposure to environmental pollutants and toxins can be extremely harmful to gametes (sperm and eggs), leading to infertility. Moreover, the rising infertility cases among women are owing to several disorders of the genital organs, growing age at conception, endocrine disorders which causes imbalances of reproductive hormones.

For instance, according to the American Pregnancy Association, nearly 30% of male population suffer from infertility and contributes to around one-fifth of infertility cases. Additionally, as per data from the Centers for the Disease Control and Prevention (CDC), around 12.1% of women, aged between 15 to 44 years are unable to conceive. Additionally, 6.7% of married women aged 15 to 44 years are infertile. Thus, the rising prevalence of infertility across the population base will stimulate market progress.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Infertility treatment devices industry was worth USD 319.3 million in 2022 and is projected to record USD 695.8 million by 2032 attributed to the development of in vitro fertilization (IVF) and other assisted reproductive technologies.

Sperm separation devices garnered USD 55.4 million in 2022 owing to the capacity of these devices to separate highly mobile sperm with competent DNA integrity from a sample of semen.

U.S. infertility treatment devices market amassed USD 120.4 million in 2022 and is estimated to witness steady growth through 2032 driven by the advancements in infertility treatment devices, favourable regulatory environment, and growing healthcare expenditure across the country.

CooperSurgical, Inc, Vitrolife AB, Cook Medical Inc, Thermo Fisher Scientific Inc, Merck KGaA, Eppendorf AG, Rocket Medical Plcs, Art Biotech Pvt. Ltd, LabIVF Asia Pte Ltd, Hamilton Thorne, Inc, IVFtech ApS, and Dxnow (ZyM?t Fertility, Inc.) are some of the top firms engaged in the market.